Focus on Hypertrophic Cardiomyopathy (HCM) Resource

An estimated 750,000 individuals in the United States have hypertrophic cardiomyopathy (HCM), and up to 20 million worldwide when genetic studies are extrapolated to populations. HCM is a genetically derived heart disease characterized by an overly thick left ventricle with a generally normal ejection fraction.

This resource, supported through an unrestricted grant from Bristol Myers Squibb, provides general information about HCM and its nonpharmacological and pharmacological treatment.

Access Resource